Rapid Respiratory Microbiological Point-of-Care Testing and Antibiotic Use in Primary Care
JAMA Internal Medicine 10.1001/jamainternmed.2026.1426May 18, 2026 at 11:00 AM EDT
Can a rapid multiplex microbiological point-of-care test (RM-POCT) safely reduce antibiotic prescribing for respiratory infections in primary care?In this randomized clinical trial that included 552 patients assigned to RM-POCT use or usual care, there was no difference in the proportion prescribed same-day antibiotics. Subgroup analyses showed differentially reduced antibiotic prescribing in patients with chronic lung disease and from whom a virus was detected; there was no difference in symptom severity for days 2 to 4.This randomized clinical trial found that use of an RM-POCT did not reduce same-day antibiotic prescribing or worsen symptom severity on days 2 to 4 in patients with respiratory infections in primary care.
Link to the article in your story
We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)
Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
Need more information? Contact us.